Adverse Drug Reactions
Labopharm to present poster on dose titration of once-daily tramadol at 3rd International Forum on Pain Medicine
Published in Health Business Week, July 20th, 2007
The poster compares two different titration schedules for Labopharm's once-daily formulation of tramadol in three Phase III clinical trials: a six-day titration to a 300 mg dose (clinical trials MDT3-002 and MDT3-003) and a nine-day titration to a 300 mg dose (clinical trial MDT3-005). The comparison showed that percentage of adverse events and discontinuations due to adverse events was similar regardless of the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
Source: Health Business Week (2007-07-20)
More Articles from Health Business Week
- A2LA
A2LA Adds Information Technology Testing to Its Fields of Accreditation - Accentia Biopharmaceuticals, Inc.
Accentia Biopharmaceuticals Appoints Pharmaceutical and Medical Device Veteran to Board of Directors - Acorda Therapeutics
Acorda Therapeutics' President and CEO Ron Cohen, M.D. Named Ernst & Young Entrepreneur of the Year 2007 Award Winner in the Metro New York Area - Acorda Therapeutics, Inc.
Acorda Therapeutics Announces Exercise of Option by Underwriters - Advanced Medical Optics, Inc.
Advanced Medical Optics Confirms $75 Per Share Proposal to Acquire Bausch & Lomb - Adverse Drug Reactions
Spectranetics Receives FDA Clearance to Market TURBO-Booster - More from this issue of Health Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
